Feedback / Questions
tilavonemab (ABBV-8E12) - AbbVie
https://cslide.ctimeetingtech.com/global_storage/media/content/adpd24/ADPD24_-_Posters_for_website_NOV_23.pdf
Esteban Cruz1; Rebecca Nisbet2; Pranesh Padmanabhan1; Ashley Van Waardenberg3; Mark Graham4; Godfrey Nkajja1; Phil Robinson4; Jürgen Götz1
Feb 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next